 |
recombinant adeno-associated virus serotype AAV8 vector encoding human ornithine transcarbamylase |
|---|---|
| Trade Name | |
| Orphan Indication | Ornithine Transcarbamylase Deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-29 00:00:00 |
| Sponsor | Dimension Therapeutics;840 Memorial Drive;Cambridge, Massachusetts, 02139 |
